Quest Partners LLC Kura Oncology, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 58,772 shares of KURA stock, worth $374,377. This represents 0.04% of its overall portfolio holdings.
Number of Shares
58,772
Previous 20,331
189.08%
Holding current value
$374,377
Previous $177 Million
119.05%
% of portfolio
0.04%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
189Shares Held
79.1MCall Options Held
76KPut Options Held
85.8K-
Bvf Inc San Francisco, CA7.75MShares$49.4 Million2.25% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.44MShares$47.4 Million2.15% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$44.4 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.57MShares$41.9 Million0.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.95MShares$31.5 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $426M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...